What is Life Length?
Life Length operates at the intersection of biotechnology and diagnostics, specializing in advanced telomere and telomerase analysis. Their core offerings include precise telomere testing, oxidative stress assessment, and clinical NAD+ measurements, all designed to provide actionable insights for promoting healthy aging and enabling preventive care strategies. Leveraging their proprietary LifeLengthTech, the company delivers high-precision analytics at a chromosomal level, catering to healthcare professionals and researchers across Europe, the USA, and Canada. Adherence to CLIA/ISO quality standards ensures the clinical-grade reliability of their reports, positioning Life Length as a key player in the personalized medicine landscape.
How much funding has Life Length raised?
Life Length has raised a total of $2.4M across 1 funding round:
Other Financing Round
$2.4M
Other Financing Round (2018): $2.4M, investors not publicly disclosed
What's next for Life Length?
The recent major strategic investment signals a pivotal growth phase for Life Length, likely enabling the company to accelerate its research and development initiatives, expand its market reach, and further commercialize its diagnostic technologies. This capital infusion is expected to bolster their efforts in oncology early diagnostics and personalized medicine, potentially leading to new product development and strategic partnerships. The company's focus on healthy aging and preventive care, combined with its robust technological platform, positions it for significant expansion and impact within the global healthcare sector.
See full Life Length company page
